摘要
目的探讨经痛汤治疗原发性痛经的疗效。方法 108例原发性痛经患者随机分为治疗组和对照组各54例,分别口服经痛汤和芬必得,连续治疗3个周期。比较两组治疗后及停药3个月痛经的视觉模拟评分(visual analogue scale,VAS)和血清前列腺素F2α(PGF2α)含量。结果治疗后及停药3个月时,两组VAS值和血清PGF2α含量比较,经痛汤组优于芬必得组,差异有统计学意义。结论经痛汤治疗原发性痛经安全有效,优于芬必得。
Objective To observe the efficacy of Jingtong decoction in treating primary dysmenorrhea. Methods A total of 108 patients with primary dysmenorrhea were randomly divided into treatment group treated with Jingtong decoction and control group treated with fenbid. The therapeutic course was 3 consecutive cycles. Visual analog scale （VAS） and serum prostaglandin F2a（PGF2a） were compared after 3 months of treatment and withdrawal three months ago. Results After treatment and withdrawal, VAS and serum PGF2a in Jingtong decoction group were superior to those in fenbid group. The difference was statistically significant. Conclusion Jingtong decoction in treating primary dysmenorrhea is effective and safe, superior to fenbid.
出处
《中国现代医生》
2014年第7期112-113,共2页
China Modern Doctor
关键词
原发性痛经
经痛汤
芬必得
前列腺素F2Α
Primary dysmenorrhea
Jingtong decoction
Fenbid
Prostaglandin F2a
